References
- Central Bureau of Health Intelligence, Government of India. National health profile 2008. New Delhi: Directorate General of Health Sciences; 2008. 102 p.
- Workshop report on Stroke surveillance in India. NewDelhi: World Health Organization 2006.
- Adams HP, del Zoppo G, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Circulation 2007;115(20):e478–534.
- Swain S, Turner C, Tyrrell P, et al. Diagnosis and initial management of acute stroke and transient ischaemic attack: summary of NICE guidance. BMJ 2008;337:a786.
- Prasad K, Kaul S, Padma MV, et al. Stroke management. Ann Indian Acad Neurol 2011;14(Suppl 1):S82–96.
- Ricci S, Celani MG, Cantisani AT, Righetti E. Piracetam for acute ischaemic stroke. Cochrane Database Syst Rev 2006;(2):CD000419.
- Clark WM, Wechsler LR, Sabounjian LA, et al. A phase III randomized efficacy trial of 2000 mg citicoline in acute ischemic stroke patients. Neurology 2001;57(9):1595–602.
- Dávalos A, Alvarez-Sabín J, Castillo J, et al. Citicoline in the treatment of acute ischaemic stroke: an international, randomised, multicentre, placebo-controlled study (ICTUS trial). Lancet 2012;380(9839):349–57.
- Roebers S, Wagner M, Ritter MA, et al. Attitudes and current practice of primary care physicians in acute stroke management. Stroke J Cereb Circ 2007;38(4):1298–303.
- Asberg S, Henriksson KM, Farahmand B, et al. Ischemic stroke and secondary prevention in clinical practice: a cohort study of 14,529 patients in the Swedish Stroke Register. Stroke J Cereb Circ 2010;41(7):1338–42.
- Filippi A, Bignamini AA, Sessa E, et al. Secondary prevention of stroke in Italy: a cross-sectional survey in family practice. Stroke J Cereb Circ 2003;34(4):1010–4.
- Bamford J, Sandercock P, Dennis M, et al. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991;337(8756):1521–6.
- Sweileh WM, Sawalha AF, Zyoud SH, et al. Discharge medications among ischemic stroke survivors. J Stroke Cereb Dis Off J Natl Stroke Assoc 2009;18(2):97–102.
- Goldstein LB, Bian J, Samsa GP, et al. New transient ischemic attack and stroke: outpatient management by primary care physicians. Arch Intern Med 2000;160(19):2941–6.
- Bhatt DL, Fox KAA, Hacke W, et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 2006;354(16):1706–17.
- Diener H-C, Bogousslavsky J, Brass LM, et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet 2004;364(9431):331–7.
- SPS3 Investigators, Benavente OR, Hart RG, McClure LA, et al. Effects of clopidogrel added to aspirin in patients with recent lacunar stroke. N Engl J Med 2012;367(9):817–25.
- Huang DY, Eisert WG. CHANCE trial: early short-term dual antiplatelet treatment for stroke prevention. Stroke J Cereb Circ 2013;44(12):3623–4.
- Wong KSL, Wang Y, Leng X, et al. Early dual versus mono antiplatelet therapy for acute non-cardioembolic ischemic stroke or transient ischemic attack: an updated systematic review and meta-analysis. Circulation 2013;128(15):1656–66.
- Ovbiagele B, Hills NK, Saver JL, Johnston SC. Antihypertensive medications prescribed at discharge after an acute ischemic cerebrovascular event. Stroke J Cereb Circ 2005;36(9):1944–7.
- Dávalos A, Alvarez-Sabín J, Castillo J, et al. Citicoline in the treatment of acute ischaemic stroke: an international, randomised, multicentre, placebo-controlled study (ICTUS trial). Lancet 2012;380(9839):349–57.
- Prasad K. Publication bias perpetuates use of ineffective drugs in stroke. Int J Stroke Off J Int Stroke Soc 2009;4(3):183–4.